Cited by 54Dementia and Cognitive Impairment ResearchAdvanced MRI Techniques and ApplicationsDiabetes, Cardiovascular Risks, and Lipoproteins

Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging

Open access
Thambisetty, Madhav, Beason-Held, Lori L., An, Yang, Kraut, Michael, Metter, Jeffrey, Egan, Josephine, Ferrucci, Luigi, O'Brien, Richard +1 more·2013·Neurobiology of Aging

Abstract

We investigated whether individuals with impaired glucose tolerance (IGT) in midlife subsequently show regionally specific longitudinal changes in regional cerebral blood flow (rCBF) relative to those with normal glucose tolerance (NGT). Sixty-four cognitively normal participants in the neuroimaging substudy of the Baltimore Longitudinal Study of Aging underwent serial (15)O-water positron emission tomography scans (age at first scan, 69.6 ± 7.5 years) and oral glucose tolerance tests 12 years earlier (age at first oral glucose tolerance test, 57.2 ± 11.1 years). Using voxel-based analysis, we compared changes in rCBF over an 8-year period between 15 participants with IGT in midlife and 49 with NGT. Significant differences were observed in longitudinal change in rCBF between the IGT and NGT groups. The predominant pattern was greater rCBF decline in the IGT group in the frontal, parietal, and temporal cortices. Some brain regions in the frontal and temporal cortices also showed greater longitudinal increments in rCBF in the IGT group. Our findings suggest that IGT in midlife is associated with subsequent longitudinal changes in brain function during aging even in cognitively normal older individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2013.03.025

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • APOE remains the only locus repeatedly associated with AAO, but PICALM and BIN1 have also been reported to affect AAO.

    “To date, APOE remains the only locus repeatedly associated with AAO8,9, but PICALM and BIN1 have also been reported to affect AAO6,10,11.”

    From A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease (2017) · cites this paper as [10]

    The Discussion (page unavailable) discusses APOE ε4 in relation to cerebral blood flow and Alzheimer’s disease risk, not age at onset (AAO). Searches for PICALM, BIN1, and APOE associations with age at onset found no passage in our copy addressing the attributed claim. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 26 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Thambisetty, M., Beason-Held, L. L., An, Y., Kraut, M., Metter, J., Egan, J., Ferrucci, L., O'Brien, R., & Resnick, S. M.
Affiliations
  • National Institutes of Health (US)
  • National Institute on Aging (US)
  • Johns Hopkins University (US)
Corresponding author
Thambisetty, Madhav
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2013-10
Volume
34
Issue
10
Pages
2271-2276
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2125733297
Cited by
54
References
26
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 7 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 8 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 1
FWCI
3.32
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Aging (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
Intramural Research Program (N01-AG-3-2124)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
impaired glucose tolerance, midlife, regional cerebral blood flow, brain aging, longitudinal brain changes, glucose tolerance, frontal cortex, parietal cortex, temporal cortex, cognitive aging, 15O-water PET, oral glucose tolerance test, Baltimore Longitudinal Study of Aging
MeSH terms
Aged, Aging, Cerebral Cortex, Cerebrovascular Circulation, Female, Follow-Up Studies, Glucose Tolerance Test, Humans, Longitudinal Studies, Male, Middle Aged, Time Factors, Glucose Intolerance, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review